Recovery of systemic hyperinflammation in patients with severe SARS-CoV-2 infection

Patients with cardiovascular disease (CVD) and acute SARS-CoV-2 infection might show an altered immune response during COVID-19. Twenty-three patients with CVD and SARS-CoV-2 infection were prospectively enrolled and received a cardiological assessment at study entry and during follow-up visit. Incl...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers 2023-01, Vol.28 (1), p.97-110
Main Authors: Langnau, Carolin, Janing, Henrik, Kocaman, Hüseyin, Gekeler, Sarah, Günter, Manina, Petersen-Uribe, Álvaro, Jaeger, Philippa, Koch, Barbara, Kreisselmeier, Klaus-Peter, Castor, Tatsiana, Rath, Dominik, Gawaz, Meinrad Paul, Autenrieth, Stella E., Mueller, Karin Anne Lydia
Format: Article
Language:English
Subjects:
Chemokines
COVID-19
Cytokines
Humans
hyperinflammation
Monocytes
platelets
recovery
SARS-CoV-2
SARS-CoV-2 infection
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with cardiovascular disease (CVD) and acute SARS-CoV-2 infection might show an altered immune response during COVID-19. Twenty-three patients with CVD and SARS-CoV-2 infection were prospectively enrolled and received a cardiological assessment at study entry and during follow-up visit. Inclusion criteria of our study were age older than 18 years, presence of CVD, and acute SARS-CoV-2 infection. The median age of the patient cohort was 69 (IQR 55-79) years. 12 (52.2%) patients were men. Peripheral monocytes and chemokine/cytokine profiles were analysed. Numbers of classical and non-classical monocytes were significantly decreased during acute SARS-CoV-2 infection compared to 3-month recovery. While classical monocytes reached the expected level in peripheral blood after 3 months, the number of non-classical monocytes remained significantly reduced. All three monocyte subsets exhibited changes of established adhesion and activation markers. Interestingly, they also expressed higher levels of pro-inflammatory cytokines like macrophage migration inhibitory factor (MIF) at the time of recovery, although MIF was only slightly increased during the acute phase. Changes of monocyte phenotypes and increased MIF expression after 3-month recovery from acute SARS-CoV-2 infection may indicate persistent, possibly long-lasting, pro-inflammatory monocyte function in CVD patients.
ISSN:1354-750X
1366-5804
DOI:10.1080/1354750X.2022.2148745